< Back to search
Filter
1

Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer

for
Metastatic Prostate Cancer
Location: Miami FL, South Pasadena CA
Sponsor: AstraZeneca

Sex: Male

Age: 18 - 70+

Code: NCT07590934

Phase1, Phase2, Recruiting

A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has Spread

for
Prostate Cancer
Location: Hackensack NJ, Portland OR
Sponsor: Regeneron Pharmaceuticals

Sex: Male

Age: 18+

Code: NCT07543055

Phase1, Recruiting

High Cardiovascular Risk Intervention With Cardio-Oncology Consultation for Prostate Cancer Following Androgen Receptor Pathway Inhibitor (ARPI) Therapy (Heart-Safe)

for
Prostate Cancer (Diagnosis), Prostate Cancer Stage IV, CV Risk
Location: Los Angeles CA
Sponsor: Cedars-Sinai Medical Center

Sex: Male

Age: 45+

Code: NCT07223385

Phase2, Recruiting

A Study to Learn About Heart-Related Risks in Elderly Men With Advanced Prostate Cancer Treated With Enzalutamide or Darolutamide

for
Prostate Cancer
Location: Whippany NJ
Sponsor: Bayer

Sex: Male

Age: 55+

Code: NCT07672119

Recruiting

Efforts to Increase Representation in Prostate Cancer Clinical Trials at Lyndon B. Johnson Hospital

for
Prostate Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: Male

Age: 18+

Code: NCT07591701

Recruiting

Interested in new prostate cancer trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer

for
Breast Cancer, Prostate Cancer, Colorectal Cancer,
Location: New York NY
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT07225309

Recruiting

A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)

for
Metastatic Castration-resistant Prostatic Neoplasms
Location: Boston MA, Hartford CT, Quebec, Mineola NY, New York NY,
Sponsor: Janssen Research & Development, LLC

Sex: Male

Age: 18+

Code: NCT07164443

Phase3, Recruiting

Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)

for
Prostate Cancer Metastatic
Location: New Haven CT, Quebec, The Bronx NY, Morristown NJ,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06136624

Phase3, Recruiting

Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.

for
Metastatic Cancer, Neoplasm, Prostate, Castrate-sensitive,
Location: The Bronx NY, New York NY, Wappingers Falls NY,
Sponsor: Sun Pharmaceutical Industries Limited

Sex: Male

Age: 18+

Code: NCT05422911

Phase2, Recruiting

Neoadjuvant High Dose Rate Brachytherapy Prior to Radical Prostatectomy in Patients With Prostate Cancer

for
Prostate Cancer (Adenocarcinoma)
Location: Houston TX
Sponsor: The Methodist Hospital Research Institute

Sex: Male

Age: 40+

Code: NCT07182279

Phase1, Phase2, Recruiting

CUIMC Focal Therapy Registry

for
Prostate Cancer
Location: New York NY
Sponsor: Columbia University

Sex: Male

Age: 40 - 70+

Code: NCT07623941

Recruiting

A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

for
Prostate Cancer
Location: Plymouth MA, Providence RI, New York NY, Hackensack NJ,
Sponsor: AstraZeneca

Sex: Male

Age: 18+

Code: NCT06952803

Phase3, Recruiting

The COSMYC Trial (COmbined Suppression of MYC)

for
Metastatic Castration-resistant Prostate Cancer
Location: Baltimore MD
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: Male

Age: 18+

Code: NCT06922318

Phase2, Recruiting

First-in-Human Study to Evaluate AZD8359 STEAP2 TCE in Participants With Prostate Cancer

for
Metastatic Prostate Cancer
Location: Providence RI, East Brunswick NJ, Orlando FL
Sponsor: AstraZeneca

Sex: Male

Age: 18 - 70+

Code: NCT07529717

Phase1, Phase2, Recruiting

Androgen Deprivation Therapy (Relugolix) for the Improvement of Diagnostic Imaging (PSMA PET/CT Scan) in Patients With High Risk or Very High Risk Prostate Cancer, The EnrichPSMA Trial

for
Prostate Adenocarcinoma, Stage IIC Prostate Cancer AJCC v8,
Location: Scottsdale AZ
Sponsor: Mayo Clinic

Sex: Male

Age: 18+

Code: NCT07025369

Phase2, Recruiting

A Ph Ib Study of REGN5678 Plus Cemiplimab in Patients With mCRPC

for
Prostate Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: Male

Age: 18+

Code: NCT06826768

Phase1, Recruiting

Evaluating In Home Cancer Therapy Versus In Clinic Cancer Therapy in Black Men With Locally Advanced, Biochemically Recurrent and Metastatic Prostate Cancer

for
Biochemically Recurrent Prostate Carcinoma,
Location: Jacksonville FL
Sponsor: Mayo Clinic

Sex: Male

Age: 18+

Code: NCT07073794

Phase2, Recruiting

Mainstreaming Genetics: Evaluation of a Digital Application to Scale and Spread Oncologist-initiated Genetic Testing

for
Cancer, Breast Cancer, Prostate Cancer, Colon Cancer,
Location: Toronto
Sponsor: Unity Health Toronto

Sex: All

Age: 18+

Code: NCT07387263

Recruiting

Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance

for
Localized Prostate Carcinoma, Stage I Prostate Cancer AJCC v8,
Location: Buffalo NY
Sponsor: Roswell Park Cancer Institute

Sex: Male

Age: 18+

Code: NCT06733350

Recruiting

A Trial to Learn How Safe AZD9750 is and How Well it Works in People With Metastatic Prostate Cancer When Given With or Without Other Anticancer Drugs

for
Prostate Cancer
Location: Boston MA, Myrtle Beach SC, Nashville TN, St Louis MO,
Sponsor: AstraZeneca

Sex: Male

Age: 18+

Code: NCT07336446

Phase1, Phase2, Recruiting